Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virol. Jun 25, 2023; 12(3): 209-220
Published online Jun 25, 2023. doi: 10.5501/wjv.v12.i3.209
Published online Jun 25, 2023. doi: 10.5501/wjv.v12.i3.209
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma
Ryuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, Yaojia Ma, Keita Ogawa, Terunao Iwanaga, Na Qiang, Junjie Ao, Ryo Nakagawa, Ryosuke Muroyama, Masato Nakamura, Tetsuhiro Chiba, Jun Kato, Naoya Kato, Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Author contributions: Kojima R and Nakamoto S contributed to the conception, design, and writing of the manuscript; Kojima R contributed to data management and analysis; Kogure T, Ma Y, Ogawa K, Iwanaga T, Qiang N, Ao J, Nakagawa R, Muroyama R, Nakamura M, Chiba T, Kato J, and Kato N contributed to manuscript review and editing; Kato N contributed to the project administration.
Institutional review board statement: This study is not applicable as it is a re-analysis of publicly available data.
Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.
Data sharing statement: All the data supporting this study are stored in the SRA database with accession number SRA335342.
ARRIVE guidelines statement: The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shingo Nakamoto, MD, PhD, Assistant Professor, Department of Gastroenterology, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan. nakamotoer@faculty.chiba-u.jp
Received: December 28, 2022
Peer-review started: December 28, 2022
First decision: January 17, 2023
Revised: February 12, 2023
Accepted: April 12, 2023
Article in press: April 12, 2023
Published online: June 25, 2023
Processing time: 174 Days and 17 Hours
Peer-review started: December 28, 2022
First decision: January 17, 2023
Revised: February 12, 2023
Accepted: April 12, 2023
Article in press: April 12, 2023
Published online: June 25, 2023
Processing time: 174 Days and 17 Hours
Core Tip
Core Tip: To understand the role of hepatitis B virus (HBV) in hepatocellular carcinoma (HCC) development, we re-analyzed HBV integration sites using publicly available data. We found that chromosome 11q13.3 is a frequently observed HBV integration site. This region contains important cancer driver genes, such as CCND1 and FGF19, which are amplified in HCC. This finding supports a mechanism of carcinogenesis promoted by HBV-induced genomic instability in the liver and provides insights into treating a subset of liver cancers.